Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 3]
Phase 3 trial comparing Keverprazan hydrochloride-amoxicillin dual therapy versus susceptibility-guided quadruple therapy for Helicobacter p…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: High-dose Dual Therapy with Different Administration Frequencies [Phase 4]
A Phase 4 clinical trial evaluating high-dose dual therapy for Helicobacter pylori infection with different dosing frequencies has completed…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Doxycycline for Helicobacter Pylori Rescue Treatment [Phase 4]
A Phase 4 clinical trial is evaluating doxycycline as a rescue treatment for Helicobacter pylori infection and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Rescue Therapy for Helicobacter Pylori Eradication Treatment [Phase 4]
Phase 4 clinical trial update indicating completion of a rescue therapy regimen for Helicobacter pylori infection; no efficacy or safety res…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
A clinical trial update from Shanghai Jiao Tong University School of Medicine studying the epidemiology of Helicobacter pylori infection and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Minocycline for Helicobacter Pylori Rescue Treatment
Clinical trial evaluating minocycline as rescue therapy for Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection [Phase 4]
A Phase 4 clinical trial update indicates ongoing recruitment for high-dose dual therapy and minocycline-containing quadruple therapy regime…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population [Phase 3]
Phase 3 trial evaluating eradication of Helicobacter pylori to prevent gastric cancer in the general population; the study is currently acti…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Tailored Vs. Empirical Helicobacter Pylori Infection Treatment [Phase 4]
Phase 4 clinical trial comparing tailored versus empirical treatment for Helicobacter pylori infection; currently NOT_YET_RECRUITING.
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under …
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study
An exploratory clinical trial evaluating a 14-day bismuth-containing quadruple therapy guided by drug susceptibility testing for extremely r…
-
FDA approval · 2024-12-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Pathogen-microbiome Interaction During Helicobacter Pylori Infection
A clinical trial update describing an ongoing study on how pathogen interactions with the microbiome influence Helicobacter pylori infection…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori [NA]
An ongoing clinical trial compares triple therapy to quadruple therapy for eradicating Helicobacter pylori. The study is sponsored by Shando…
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori [Phase 4]
Phase 4 clinical trial update on optimizing vonoprazan-based dual therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis. [NA]
A clinical trial at National Cheng-Kung University Hospital is examining whether probiotics can regulate microRNA during H. pylori–induced g…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains [Phase 4]
Phase 4 clinical trial evaluating susceptibility-guided bismuth quadruple therapy for multiple-drug-resistant Helicobacter pylori has comple…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: 14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection [Phase 4]
Phase 4 trial completed evaluating a 14-day susceptibility-guided bismuth quadruple therapy for multidrug-resistant Helicobacter pylori infe…
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity
Completed real-world study evaluating Helicobacter pylori eradication regimens in patients with comorbidities. The update notes the trial's …
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males [Phase 4]
Phase 4 clinical trial evaluating the optimal duration of bismuth quadruple therapy for Helicobacter pylori infection, comparing outcomes in…
-
FDA approval · 2024-11-05FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for rabeprazole sodium (Amneal Pharmaceuticals LLC).
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.